Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with imp...

著者: Brunvand, Mark W., Bitter, Mitchell
出版事項 2010

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

著者: Brunvand, Mark W., Carson, John
出版年 Hematol Oncol (2017)

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20 + indolent NHL: Correlation between clinical responses and AUC pharmac...

著者: Casulo, Carla, Vose, Julie M., Ho, William Y., Kahl, Brad, Brunvand, Mark, Goy, Andre, Kasamon, Yvette, Cheson, Bruce, Friedberg, Jonathan W.
出版年 Clin Immunol (2014)

Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

著者: Advani, Ranjana H., Lebovic, Daniel, Chen, Andy, Brunvand, Mark, Goy, Andre, Chang, Julie E., Hochberg, Ephraim, Yalamanchili, Sreeni, Kahn, Robert, Lu, Dan, Agarwal, Priya, Dere, Randall C., Hsieh, Hsin-Ju, Jones, Surai, Chu, Yu-Waye, Cheson, Bruce D.
出版年 Clin Cancer Res (2016)